Oxsed Revenue and Competitors

-,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Oxsed's estimated annual revenue is currently $1.4M per year.(i)
  • Oxsed's estimated revenue per employee is $155,000

Employee Data

  • Oxsed has 9 Employees.(i)
  • Oxsed grew their employee count by -18% last year.

Oxsed's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Oxsed?

Oxsed has developed a rapid, accurate and scalable COVID-19 test that leverages patent-pending OxLAMP technology from the University of Oxford. In recent months, we have ramped up testing in the UK and have tested thousands of people daily, including passengers at Heathrow Airport. Last year, we were acquired by Prenetics in Hong Kong, a leader in digital health and diagnostics. We are committed to making COVID-19 testing accessible and affordable to everyone, and are well positioned to scale diagnostic and mass surveillance testing globally.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$1.4M

Revenue (est)

-18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Oxsed News

2022-03-30 - TWL Holdings inks MoU with Tatra Investment to penetrate in ...

Tan said this was developed jointly by a Hong Kong-based company Prenetics Ltd and a leading research company, Oxsed, based at Oxford University...

2022-02-22 - Oxford, Prenetics to take their COVID-19 rapid testing tech to other ...

The partnership follows Prenetics' acquisition of Oxsed, the spinout behind the University of Oxford's nasal swab rapid diagnostic test for...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M12-14%N/A
#2
$1M13N/AN/A
#3
$1.7M1912%N/A
#4
$1.6M28155%N/A
#5
$7.7M386%N/A